HBsAg Testing Market Size

Hepatitis B Tests Market size was valued at USD 1.33 billion in 2023 and is likely to reach USD 2.77 billion by 2036, registering around 5.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of hepatitis B tests is assessed at USD 1.39 billion. The growth of the market can be attributed to the growing prevalence of hepatitis B, and increasing awareness levels among patients associated with early detection of the disease. According to the World Health Organization, in 2019, 296 million in the world were living with chronic hepatitis B infection, with 1.5 million new infections every year. That same year, hepatitis B resulted in the deaths of 820,000 people globally. Along with these, rise in technological advancements in molecular diagnostics, and upsurge in blood transfusion and donations in patients with hepatitis are also expected to drive market growth significantly in the forthcoming years. Furthermore, rapidly growing biotechnology and biopharmaceutical industries around the world is projected to offer profitable opportunities to the market in the near future.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of hepatitis B tests is assessed at USD 1.39 billion.

Hepatitis B Tests Market size was valued at USD 1.33 billion in 2023 and is likely to reach USD 2.77 billion by 2036, registering around 5.8% CAGR during the forecast period i.e., between 2024-2036. The market growth is driven by growing prevalence of hepatitis B, and increasing awareness among about early detection of the disease.

Asia Pacific industry is estimated to dominate majority revenue share by 2036, backed by large number of patients, and growing occurrence of hepatitis in the region.

The major players in the market are Abbott Laboratories, F. Hoffman-La Roche AG, Siemens AG, Bio-Rad Laboratories, Inc., Danaher Corporation, and others.

HBsAg Testing Market Size